Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma

Medical Oncology

Volumn 27, Issue 4, 2010, Pages 1185-1191

  Chen, Tiefu ^a   Zhu, Jie ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

EMMPRIN; MMP 2; Primary cutaneous malignant melanoma; Survival

Indexed keywords

BIOLOGICAL MARKER; CD147 ANTIGEN; FORMALDEHYDE; GELATINASE A; PARAFFIN;

ADULT; AGE; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; THICKNESS; TISSUE SECTION; TUMOR LOCALIZATION;

ANTIGENS, CD147; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79951773674     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9357-y     Document Type: Article

References (29)

1. Veit-Haibach P, Vogt FM, Jablonka R, et al. Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma. Eur J Nucl Med Mol Imaging. 2009;36:910-8.
2. Fang X, Zhang X, Li J. Up-regulation of human leukocyte antigen G expression in primary cutaneous malignant melanoma associated with host-vs-tumor immune response. J Huazhong Univ Sci Technolog Med Sci. 2008;28:219-21.
3. High WA, Stewart D, Wilbers CR, et al. Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria. J Am Acad Dermatol. 2005;53:89-100. (Pubitemid 40826701)
4. Biswas C, Zhang Y, DeCastro R, et al. The human tumor cellderived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55:434-9.
5. Li RS, Huang L, Guo HM, et al. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol. 2001;186:371-9. (Pubitemid 32147720)
6. Zucker S, Hymowitz M, Rollo EE, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol. 2001;158:1921-8. (Pubitemid 32545174)
7. Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer. 2002;99:520-8. (Pubitemid 34461604)
8. Muramatsu T, Miyauchi T. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol. 2003;18:981-7. (Pubitemid 36773240)
9. Gu J, Zhang C, Chen R, et al. Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas. Eur J Pediatr. 2009;168:705-10.
10. Jia L, Xu H, Zhao Y, et al. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma. Cancer Invest. 2008;26:977-83.
11. Zhong WD, Han ZD, He HC, et al. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology. 2008;75:230-6.
12. Tan H, Ye K, Wang Z, Tang H. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma. Transl Res. 2008;152:143-9.
13. Yuichiro Y, Kageshita T, et al. Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and-2 in patients with malignant melanoma. J Dermatol. 2008;35:206-14. (Pubitemid 351561711)
14. Breslow A. Thickness, cross-sectional area, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902-8.
15. Clark WH, From L, Bernadino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29:705-26.
16. American Joint Committee on Cancer. Malignant melanoma of the skin. In: Fleming I, Cooper J, Henson D, editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 163-70.
17. Ishibashi Y, Matsumoto T, Niwa M, et al. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer. 2004;101:1994-2000. (Pubitemid 39425374)
18. Taylor PM, Woodfield RJ, Hodgkin MN, et al. Breast cancer cellderived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A (2) and 5-lipoxygenase catalyzed pathway. Oncogene. 2002;21:5765-72. (Pubitemid 35333010)
19. Guo H, Zucker S, Gordon MK, et al. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem. 1997;272:24-7. (Pubitemid 27021117)
20. Sameshima T, Nabeshima K, Toole BP, et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett. 2002;157:177-84. (Pubitemid 30629029)
21. Toole BP. EMMPRIN (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol. 2003;54:371-89. (Pubitemid 137639474)
22. Tang Y, Nakada MT, Kesavan P, et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res. 2005;65:3193-9. (Pubitemid 40524601)
23. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18:1135-49. (Pubitemid 30123793)
24. Lim M, Martinez T, Jablons D, et al. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett. 1998;441:88-92. (Pubitemid 29012378)
25. Biswas C. Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun. 1982;109:1026-34. (Pubitemid 13149714)
26. Biswas C. Collagenase stimulation in cocultures of human fibroblasts and human tumor cells. Cancer Lett. 1984;24:201-7. (Pubitemid 14012180)
27. Morgia G, Falsaperla M, Malaponte G, Madonia M, Indelicato M, Travali S, et al. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer. Urol Res. 2005;33:44-50. (Pubitemid 40487192)
28. Redondo P, Lloret P, Idoate M, Inoges S. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression. Clin Exp Dermatol. 2005;30:541-5. (Pubitemid 41076024)
29. Sier CF, Zuidwijk K, Zijlmans HJ, et al. EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma. Int J Cancer. 2006;118:2991-8.